Trials / Completed
CompletedNCT00891540
Local Infiltration Analgesia With Ropivacaine Versus Placebo in Caesarean Section
Lokal Infiltrations Analgesi Med Ropivakain 0,5 % Versus Ropivakain 0,2 % Versus Placebo Efter Sectio Caesarea: et Prospektivt, Dobbeltblindet, Placebokontrolleret Studie.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Hvidovre University Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare systematic local infiltration with Ropivacaine 0.5 % versus Ropivacaine 0.2 % versus Placebo in patients undergoing elective caesarean section. The hypothesis is that systemic local infiltration will reduce pain and postoperative opioid consumption.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine | Ropivacaine 0.5% |
| DRUG | Ropivacaine | Ropivacaine 0.2% |
| DRUG | placebo | Isotonic NaCl |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-05-01
- Completion
- 2010-05-01
- First posted
- 2009-05-01
- Last updated
- 2011-06-23
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00891540. Inclusion in this directory is not an endorsement.